Standardization of production and anti-herpetic evaluation of a recombinant interferon beta molecule
DOI:
https://doi.org/10.17533/udea.hm.12649Keywords:
herpes simplex virus , cell culture , interferon β, antiviral, bioassayAbstract
Downloads
References
Akhtar J, Shukla D. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J. 2009; 276: 7228-36.
Amir J, Harel L, Smetana Z, Varsano I. Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study. Br Med J. 1997; 314: 1800-3.
Penfold ME, Armati P, Cunningham AL. Axonal transport of herpes simplex virions to epidermal cells: evidence for a specialized mode of virus transport and assembly. Proc Natl Acad Sci U S A. 1994; 91: 6529-33.
Sawtell NM, Thompson RL. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol. 1992; 66: 2150-6.
Ship II, Miller MF, Ram C. A retrospective study of recurrent herpes labialis (RHL) in a professional population, 1958-1971. Oral Surg Oral Med Oral Pathol. 1977; 44: 723-30.
Marín LM. Expresión de oligoadenilato sintetasa 1b (OAS-1b) en neuronas trigeminales infectadas con HSV-1. Trabajo de grado, Facultad de Odontología, Universidad Nacional de Colombia. 2007.
Sun, Y, Kum, R, Hoon, S, Pei, P. Detection and Genotyping of Human Herpes Simplex Viruses in Cu-taneous Lesions of Erythema Multiforme by Nested PCR. J Med Virol 2003; 71: 423-428.
Al-khatib K, Williams BR, Silverman RH, Halford W, Carr DJ. The murine double-stranded RNA-dependent protein kinase PKR and the murine 2’,5’-oli-goadenylate synthetase-dependent RNase L are required for IFN-beta-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture. Virology 2003; 313:126-35.
Samuel S. Antiviral Actions of Interferons. Clin Microbiol Rev. 2006; 14: 778 – 809.
Poon AW, Gu H, Roizman B. ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proc Natl Acad Sci U S A. 2006; 103: 9995-99.
Chee AV, Roizman B. Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J Virol. 2004; 78: 4185-96.
Maheshwari R, Friedman R. E!ect of interferon treatment on vesicular stomatitis virus (VSV): Release of unusual particles with low infectivity. Virology 1980; 101: 399 – 407.
McSharry J, Compans R and Choppin P. (1971). Proteins of Vesicular Stomatitis Virus and of Phenotypically Mixed Vesicular Stomatitis Virus-Simian Virus 5 Virions. J Virol. 1971; 8: 722-29.
Cui B, Carr DJ. A plasmid construct encoding murine interferon beta antagonizes the replication of herpes simplex virus type I in vitro and in vivo. J Neuroimmunol. 2000; 108: 92 - 102.
Härle P, Cull V, Agbaga M, Silverman R, Williams B, James C, Carr DJ. Di!erential e!ect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. J Virol. 2002; 76: 6558-67.
Härle P, Noisakran S, Carr DJ. T h e a p p l i c a t i o n o f a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice. J Immunol. 2001; 166: 1803-12.
Sainz B, Halford W. Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J Virol. 2002; 76: 11541-50.
Pierce A, DeSalvo J, Foster T, Kosinski A, Weller S and Halford W. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. J Gen Virol. 2005; 86: 2421–32.